CANADA PENSION PLAN INVESTMENT BOARD
PensionPosition in AKBA — Akebia Therapeutics, Inc.
CIK 1283718
TORONTO ONTARIO, A6
Position in AKBA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$399,625
-$120,244 QoQ
Shares Held
287,500
-11.0% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CANADA PENSION PLAN INVESTMENT BOARD holds $154,161,196 across 22 Drug Manufacturers - Specialty & Generic names. AKBA ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
649,339 | $76,758,363 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,427,676 | $43,001,601 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
89,100 | $11,738,034 | |
| 4 | VTRS |
Viatris Inc
|
471,863 | $6,374,869 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
4,840 | $2,870,023 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
491,168 | $2,652,307 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
374,800 | $2,173,840 | |
| 8 | ALKS |
Alkermes plc.
|
48,500 | $1,714,960 |
All Filings in AKBA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $399,625 | 287,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $519,869 | 322,900 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||